Active Biotech: First Patient Recruited in Myelofibrosis - Redeye
Bildkälla: Stockfoto

Active Biotech: First Patient Recruited in Myelofibrosis - Redeye

Redeye is positive about the HOVON study starting recruitment and provides a brief comment.

Redeye is positive about the HOVON study starting recruitment and provides a brief comment.
Börsvärldens nyhetsbrev
ANNONSER